标题
From Magic Bullet to Magic Bomb: Reductive Bioactivation of Antiparasitic Agents
作者
关键词
-
出版物
ACS Infectious Diseases
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2021-09-02
DOI
10.1021/acsinfecdis.1c00118
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites
- (2020) Jakob Birnbaum et al. SCIENCE
- Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned
- (2020) Ryan Choi et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Toxoplasma gondii requires its plant-like heme biosynthesis pathway for infection
- (2020) Amy Bergmann et al. PLoS Pathogens
- Advances in the research on the targets of anti-malaria actions of artemisinin
- (2020) Jing Yang et al. PHARMACOLOGY & THERAPEUTICS
- Genetic screens reveal a central role for heme metabolism in artemisinin susceptibility
- (2020) Clare R. Harding et al. Nature Communications
- One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases
- (2020) Wesley C. Van Voorhis et al. VETERINARY PARASITOLOGY
- Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections
- (2020) Andrea Schiefer et al. PLoS Neglected Tropical Diseases
- Two successful decades of Swiss collaborations to develop new anti-malarials
- (2019) Rob Hooft van Huijsduijnen et al. MALARIA JOURNAL
- Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections
- (2019) Malina A. Bakowski et al. Science Translational Medicine
- The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
- (2019) Eric Pelfrene et al. PLoS Neglected Tropical Diseases
- Stochastic Protein Alkylation by Antimalarial Peroxides
- (2019) Joëlle Jourdan et al. ACS Infectious Diseases
- Ozonide Antimalarials Alkylate Heme in the Malaria Parasite Plasmodium falciparum
- (2019) Carlo Giannangelo et al. ACS Infectious Diseases
- New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice
- (2019) Andreas K Lindner et al. LANCET INFECTIOUS DISEASES
- Anti-malarial ozonides OZ439 and OZ609 tested at clinically relevant compound exposure parameters in a novel ring-stage survival assay
- (2019) Annabelle Walz et al. MALARIA JOURNAL
- Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial
- (2018) Victor Kande Betu Ku Mesu et al. LANCET
- Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us
- (2018) Bruno L. Travi et al. PLoS Neglected Tropical Diseases
- Nitro-Group-Containing Drugs
- (2018) Kunal Nepali et al. JOURNAL OF MEDICINAL CHEMISTRY
- Artemisinin, the Magic Drug Discovered from Traditional Chinese Medicine
- (2018) Jigang Wang et al. Engineering
- Transporters of Trypanosoma brucei -phylogeny, physiology, pharmacology
- (2017) Remo S. Schmidt et al. FEBS Journal
- Seeking the Elusive Long-Acting Ozonide: Discovery of Artefenomel (OZ439)
- (2017) Ho Shin Kim et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
- (2017) James S McCarthy et al. LANCET INFECTIOUS DISEASES
- Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro
- (2017) Judith Straimer et al. mBio
- A Click Chemistry-Based Proteomic Approach Reveals that 1,2,4-Trioxolane and Artemisinin Antimalarials Share a Common Protein Alkylation Profile
- (2016) Hanafy M. Ismail et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium falciparum Strains
- (2016) Tuo Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Endoperoxide Drug Cross-Resistance Patterns for Plasmodium falciparum Exhibiting an Artemisinin Delayed-Clearance Phenotype
- (2016) A. Siriwardana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of OZ439 (artefenomel) against earlyPlasmodium falciparumblood-stage malaria infection in healthy volunteers
- (2016) James S. McCarthy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
- (2016) Aung Pyae Phyo et al. LANCET INFECTIOUS DISEASES
- Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study
- (2016) Neena Valecha et al. MALARIA JOURNAL
- Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasitesPlasmodium falciparum3D7
- (2016) Hanafy M. Ismail et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy
- (2015) Carlos A. Morillo et al. NEW ENGLAND JOURNAL OF MEDICINE
- A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
- (2015) Margaret A. Phillips et al. Science Translational Medicine
- Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
- (2015) Jigang Wang et al. Nature Communications
- Chimerization at the AQP2–AQP3 locus is the genetic basis of melarsoprol–pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates
- (2015) Fabrice E. Graf et al. International Journal for Parasitology-Drugs and Drug Resistance
- Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel)
- (2015) Joëlle Jourdan et al. ACS Infectious Diseases
- Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
- (2014) Elizabeth A. Ashley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
- (2014) Israel Molina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action
- (2014) Dominic Birth et al. Nature Communications
- Iron and heme metabolism in Plasmodium falciparum and the mechanism of action of artemisinins
- (2013) Nectarios Klonis et al. CURRENT OPINION IN MICROBIOLOGY
- Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs
- (2013) J. C. Munday et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cryo-electron tomography reveals four-membrane architecture of the Plasmodium apicoplast
- (2013) Leandro Lemgruber et al. MALARIA JOURNAL
- Chitin Synthase Inhibitors as Antifungal Agents
- (2013) Preeti M. Chaudhary et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- The folate metabolic network of Falciparum malaria
- (2013) J. Enrique Salcedo-Sora et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Assessing the Essentiality of Leishmania donovani Nitroreductase and Its Role in Nitro Drug Activation
- (2012) S. Wyllie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials
- (2012) Joerg J. Moehrle et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Treatment of MDR1 Mutant Dogs with Macrocyclic Lactones
- (2012) Joachim Geyer et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The genome of the heartworm, Dirofilaria immitis, reveals drug and vaccine targets
- (2012) Christelle Godel et al. FASEB JOURNAL
- Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)
- (2012) D. Tweats et al. MUTAGENESIS
- Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
- (2012) Y. Yuthavong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes
- (2012) N. Baker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping Sickness
- (2011) Marcel Kaiser et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia
- (2011) D. Leitsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Molecular Basis of Folate Salvage inPlasmodium falciparum
- (2011) J. Enrique Salcedo-Sora et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies PotentPlasmodium falciparumDihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
- (2011) Jose M. Coteron et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
- (2011) S. A. Charman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the Wolbachia Cell Division Protein FtsZ as a New Approach for Antifilarial Therapy
- (2011) Zhiru Li et al. PLoS Neglected Tropical Diseases
- Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium
- (2010) Amy K Wernimont et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness
- (2010) Els Torreele et al. PLoS Neglected Tropical Diseases
- Probing the Antimalarial Mechanism of Artemisinin and OZ277 (Arterolane) with Nonperoxidic Isosteres and Nitroxyl Radicals
- (2009) M. A. Fugi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wolbachia: more than just a bug in insects genitals
- (2009) Aggeliki Saridaki et al. CURRENT OPINION IN MICROBIOLOGY
- Ergosterol biosynthesis and drug development for Chagas disease
- (2009) Julio A Urbina MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance
- (2009) David Leitsch et al. MOLECULAR MICROBIOLOGY
- Relationship between Antimalarial Activity and Heme Alkylation for Spiro- and Dispiro-1,2,4-Trioxolane Antimalarials
- (2008) D. J. Creek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Wolbachia endosymbiont of Brugia malayi has an active pyruvate phosphate dikinase
- (2008) Sylvine Raverdy et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- The Wolbachia endosymbiont of Brugia malayi has an active phosphoglycerate mutase: a candidate target for anti-filarial therapies
- (2008) Jeremy M. Foster et al. PARASITOLOGY RESEARCH
- Genotyping of Benzimidazole-Resistant and Dicarboximide-Resistant Mutations inBotrytis cinereaUsing Real-Time Polymerase Chain Reaction Assays
- (2008) Shinpei Banno et al. PHYTOPATHOLOGY
- A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
- (2008) Shane R. Wilkinson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started